TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2025)
TELA Bio has reported Total Non-Current Liabilities over the past 8 years, most recently at $73.6 million for Q4 2025.
- Quarterly results put Total Non-Current Liabilities at $73.6 million for Q4 2025, up 29.81% from a year ago — trailing twelve months through Dec 2025 was $73.6 million (up 29.81% YoY), and the annual figure for FY2025 was $73.6 million, up 29.81%.
- Total Non-Current Liabilities for Q4 2025 was $73.6 million at TELA Bio, up from $58.5 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for TELA hit a ceiling of $73.6 million in Q4 2025 and a floor of $36.6 million in Q1 2021.
- Median Total Non-Current Liabilities over the past 5 years was $55.3 million (2022), compared with a mean of $52.7 million.
- Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 35.11% in 2022 and later decreased 1.32% in 2024.
- TELA Bio's Total Non-Current Liabilities stood at $42.1 million in 2021, then rose by 24.37% to $52.3 million in 2022, then grew by 9.87% to $57.5 million in 2023, then decreased by 1.32% to $56.7 million in 2024, then increased by 29.81% to $73.6 million in 2025.
- The last three reported values for Total Non-Current Liabilities were $73.6 million (Q4 2025), $58.5 million (Q3 2025), and $57.1 million (Q2 2025) per Business Quant data.